Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists test new way to speed up TB research in humans

NCT ID NCT05592223

Summary

This study aimed to develop a new, faster method for testing future tuberculosis (TB) drugs and vaccines. Twenty healthy volunteers received a small, safe skin injection of the BCG vaccine (a weakened TB-related germ). Researchers then took skin samples to see how the body reacted and how two common TB antibiotics affected the injection site. The goal was to create a tool to help future studies find better TB treatments more quickly.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fred Hutchinson Cancer Center

    Seattle, Washington, 98109, United States

Conditions

Explore the condition pages connected to this study.